Home>Topics>Stocks>NuVasive

NuVasive NUVA

  1. All
  2. Commentary
  3. Stock Reports
  4. Fund Reports
  5. Headlines
    1. Medtech Shifts From High Gear Into Overdrive: Canaccord's William Plovanic

      Headlines

      Wed, 20 Aug 2014

      By Life Sciences Report : Rapid growth in the medical device industry and changes in the regulatory environment have propelled valuations in the medtech sector to the high end of the range. But new technologies create new investment opportunities. In this interview with The Life Sciences Report ,

    2. New finance chief at Cytori

      Headlines

      Mon, 18 Aug 2014

      Cytori Therapeutics ( CYTX -1.2% ) appoints Tiago Girao as VP of Finance and CFO effective September 2, 2014. He joins the firm from NuVasive where he was International Controller. Post your comment!

    3. Update: Judge Cancels NuVasive's Trademark On The NeuroVision Name

      Headlines

      Tue, 12 Aug 2014

      By Andy Batts : NuVasive 's (NASDAQ: NUVA ) bid to escape a $30 ..... negative catalyst for NuVasive 's stock, but I feel ..... it, especially after NUVA posted excellent second ..... 2010, it was found that NuVasive infringed the NeuroVision

    4. Goldman's picks in small caps

      Headlines

      Tue, 5 Aug 2014

      Also included are Health Care names: Agios Pharmaceuticals ( AGIO -1.1% ), NPS Pharma ( NPSP +0.7% ), NuVasive ( NUVA -1.8% ), Synageva ( GEVA -1.6% ); Consumer Staples: Darling Ingredients ( DAR -0.8% ); Materials

    5. NuVasive Running On Renewed MIS Vigor

      Headlines

      Thu, 31 Jul 2014

      percentage of overall cases. That's great news for NuVasive (NASDAQ: NUVA ), as is progress toward the sort of operating margins ..... orthopedics space have been relatively lackluster, but NuVasive was a definite exception this time around. Revenue

    6. NuVasive's ( NUVA ) CEO Alexis Lukianov on Q2 2014 Results - Earnings Call Transcript

      Headlines

      Tue, 29 Jul 2014

      NuVasive (NASDAQ: NUVA ) Q2 2014 Earnings Call July 29, 2014 5:30 pm ET Executives Carol A. Cox - Executive Vice President of Strategy and Corporate

    7. NuVasive ups revenue guidance after Q2 results

      Headlines

      Tue, 29 Jul 2014

      NuVasive ( NUVA -0.1% ) Q2 results : Revenue: $190.7M (+15.1%); Gross Profit: $145.8M (+24.6%); Operating Expenses

    8. NuVasive beats by $0.03, beats on revenue

      Headlines

      Tue, 29 Jul 2014

      NuVasive (NASDAQ: NUVA ): Q2 EPS of $0.28 beats by $0.03 . Revenue of $190.67M (+15.1% Y/Y) beats by $13.17M . Shares +4.12% AH. Press Release Post your comment!

    9. Notable earnings after Tuesday's close

      Headlines

      Mon, 28 Jul 2014

      GPN , GPRE , HTA , HURN , IGT , INAP , INVN , IPHI , IVR , KIM , LNDC , MAR , MOVE , NATI , NCR , NEM , NEU , NFX , NTRI , NUVA , PEI , PLT , PNRA , QGEN , RBC , RGR , RKT , RNG , RNR , ROG , RPXC , RT , RUBI , SB , SLCA , SM , SQNM , TMH , TRN , TWTR

    10. Bernanke’s Santa Claus Cheer

      Headlines

      Fri, 27 Dec 2013

      NuVasive 's fortunes are bound to spinal fusion.

    « Prev1234Next »
    Content Partners